Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

The four types of dementia most people don’t know exist

What most people think of when they hear the word “dementia” is memory problems and forgetfulness. But what people often don’t know is that dementia can cause many different symptoms – affecting speech, behaviour, sleep, motor function and more.

The Conversation

Vagus nerve stimulation shows promise as a way to counter Alzheimer’s disease- and age-related memory loss

Most people think of Alzheimer’s disease as an illness of aging. But in fact, the brain changes that characterize it begin much earlier – sometime around the third decade of life.

The Conversation

NHS watchdog to review evidence on two pioneering Alzheimer’s drugs

Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their benefits “too small” to justify the cost

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Hormone therapy and dementia risk: what a new study says about menopause treatment

Hormone therapy is widely used to treat menopausal symptoms such as hot flushes and night sweats. But scientists have long debated whether it affects dementia risk.

The Conversation

Reading, puzzles and learning new skills may help delay Alzheimer’s disease, study suggests

Keeping your brain active throughout life by learning new skills or reading could help delay Alzheimer’s disease.

Euronews

Beyond the Slopes: Mikaela Shiffrin’s Mission to Help Educate Families Facing Early Symptomatic Alzheimer’s Disease

Mikaela was compensated for her time by Eli Lilly and Company. The Most Decorated Skier of Our Time Mikaela Shiffrin knows what it means to chase down a challen

Sports Illustrated

Single protein could dramatically alter trajectory of Alzheimer's disease

In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.

LiveScience

Read news from The Economist, FT, and more,
with one subscription

Researchers say AI can predict Alzheimer’s disease with close to 93 percent accuracy

More than 7 million Americans are living with the degenerative neurological disorder

The Independent UK

Common Pneumonia Bacterium Found in the Eye May Contribute to Alzheimer's Disease Risk

Research links pneumonia bacterium Alzheimer's risk through retinal infection and inflammation, expanding Alzheimer's disease risk factors.

Medical Daily

Reading and writing can lower dementia risk by almost 40%, study suggests

Cognitive health in later life is ‘strongly influenced’ by lifelong exposure to intellectually stimulating environments, say researchers

The Guardian - UK

Books, writing and learning languages proven to slash Alzheimer’s risk

Experts say maintaining an active brain can stave off a decline in crucial thinking skills and memory

The Independent UK

The finger prick blood test that could revolutionise Alzheimer’s diagnosis

The test aims to pick up three proteins known to be associated with Alzheimer’s

The Independent UK

The common diabetes symptom linked to increased risk of Alzheimer’s disease

A new study has found that people who experience post-meal blood sugar spikes are more likely to develop Alzheimer’s disease

The Independent UK

Alzheimer’s therapies should target a particular gene, researchers say

Scientists at UCL say drug developers should focus on two risk-raising variants of the Apoe gene

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Most Alzheimer’s cases linked to a single gene, study finds

One gene called APOE has long been known to increase the risk of Alzheimer’s disease, but without a specific variant most cases would not occur

The Conversation

Small study finds microdoses of cannabis stalled cognitive decline in Alzheimer’s patients

As the world’s population ages, the number of people living with dementias such as Alzheimer’s disease increases. Given the lack of curative treatments and the limited effectiveness of available medications, interest in new therapeutic approaches is growing. Among them are cannabinoids from the cannabis plant.

The Independent UK

Breakthrough Alzheimer’s blood test could diagnose disease earlier

Experts described the disease as a ‘global challenge’

The Independent UK

This gross habit could reduce your risk of alzheimer’s by 37%, according to experts

Certain amounts of hydrogen sulfide can help protect aging brains from Alzheimer’s disease, according to a 2021 study

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Weight loss jab could be used to slow progression of Alzheimer’s disease in major breakthrough

Liraglutide, sold under the brand name Saxenda, is already prescribed on the NHS as a weight loss medication

The Independent UK

Obesity speeds up the development of Alzheimer’s disease, study reveals

Obesity is associated with an increase in dementia risk and researchers can now see that it speeds up the development of Alzheimer’s in particular

The Independent UK

Scientists reveal how many steps you need to walk daily to reduce Alzheimer’s risk

A new 14-year study is one of the first to explore the relationship between activity and key markers of the disease

Evening Standard

Walking for more than 5,000 steps per day may reduce Alzheimer’s risk – study

There was a slowing in the build-up of a protein called tau, which becomes abnormal in Alzheimer’s.

Barchart

2 ‘Strong Buy’ Stocks That Wall Street Believes Can Soar 360% to 780%

These two growth stocks are attractive for investors seeking big upside in exchange for higher risk.

The Independent UK

NHS risks missing ‘new era’ of Alzheimer’s treatment without major reforms, experts warn

A new ‘medical revolution’ in treating Alzheimer’s disease is coming, a leading professor says

Evening Standard

NHS ‘not ready’ for new era of Alzheimer’s diagnosis and treatment, experts say

It comes as a series of papers by 40 experts said a ‘concerted societal effort’ is needed to ensure patients benefit fully from scientific advances.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Eli Lilly and Company

Johns Hopkins Medicine

21 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.